articleTop 1% cited

Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma

Journal of Allergy and Clinical Immunology · 2012 · Vol. 131(1) · pp. 110–116.e1

Philippe Gevaert✉(Ghent University)Lien Calus(Ghent University Hospital)Thibaut Van Zele(Ghent University Hospital)Katrien Blomme(Ghent University Hospital)Natalie De Ruyck(Ghent University Hospital)Wouter Bauters(Ghent University Hospital)Peter W. Hellings(KU Leuven)Guy Brusselle(Ghent University Hospital)Dirk De Bacquer(Ghent University)Paul Van Cauwenberge(Ghent University Hospital)Claus Bachert(Ghent University Hospital)

View via DOI Publisher page

Allergic Rhinitis and Sensitization Asthma and respiratory diseases Sinusitis and nasal conditionsOmalizumabMedicineNasal polypsAsthmaImmunoglobulin ENasal congestionPlaceboInternal medicineQuality of life (healthcare)Nonallergic rhinitis

MeSH terms

OmalizumabAdultAntibodies, Anti-IdiotypicAsthmaFemaleHumansMaleMiddle AgedNasal PolypsTreatment OutcomeAnti-Allergic AgentsAntibodies, Monoclonal, Humanized

Citations

734

FWCI

18.44

field-weighted impact

References

Percentile

100%

vs. same field & year

Citations per year

Cited by

Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers

Journal of Allergy and Clinical Immunology · 2016 · 1,112 citations

References

The MOS 36-ltem Short-Form Health Survey (SF-36)

Medical Care · 1992 · 29,431 citations

Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.